We assign a technical rating of 2 out of 10 to ENOB. In the past year, ENOB was a below average performing stock in the market. The medium term picture is also negative, but we see some improvement happening in recent action.
When comparing the yearly performance of all stocks, ENOB is a bad performer in the overall market: 97% of all stocks are doing better.
ENOB is part of the Biotechnology industry. There are 562 other stocks in this industry, of which 79% are performing better than ENOB.
ENOB is currently trading in the lower part of its 52 week range. The S&P500 Index however is trading in the upper part of its 52 week range, so ENOB is lagging the market.
Considerably lower volume is observed in the last couple of days, which is not what you would like to see during a strong up movement.
In the last month ENOB has a been trading in the 0.46 - 0.76 range, which is quite wide. It is currently trading near the high of this range.
The short term trend is positive, while the long term trend is still negative. So this is evolving in the right direction, but it may need some more time to really turn around the trend.
Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.